{"filing":{"accession_number":"0001493152-26-041656","cik":"0001595353","ticker":"GLMD","company_name":"Galmed Pharmaceuticals Ltd.","form":"6-K","filing_date":"2026-09-08","report_date":"2026-09-08","primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1595353/000149315226041656/form6-k.htm"},"events":[{"id":31722,"run_id":29124,"accession_number":"0001493152-26-041656","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that Galmed regained compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)) after previously failing to maintain $1.00 per share for 30 consecutive trading days. The Company was notified of non-compliance on January 29, 2026, given a 180-day cure period (extended to 360 days total), and ultimately achieved compliance by September 3, 2026. This is a delisting-risk resolution: the Company faced potential delisting and has now cured the deficiency, bringing it back into full compliance with all applicable listing standards.","company_name":"Galmed Pharmaceuticals Ltd.","ticker":"GLMD","filing_date":"2026-09-08","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":34690,"accession_number":"0001493152-26-041656","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Galmed regained compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)) after previously failing to maintain $1.00 per share for 30 consecutive trading days. The Company was notified of non-compliance on January 29, 2026, given a 180-day cure period (extended to 360 days total), and ultimately achieved compliance by September 3, 2026. This is a delisting-risk resolution: the Company faced potential delisting and has now cured the deficiency, bringing it back into full compliance with all applicable listing standards.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-08T10:10:18.091687+00:00","company_name":"Galmed Pharmaceuticals Ltd.","ticker":"GLMD","filing_date":"2026-09-08"}]}